CEO itself told me that they expect minimum 2 new Partnerships for this year which will bring more cash to IGXT .
IGXT has 10 Drugs in Pipeline all these drugs will be on the Market within 2-3 Years many of them have Huge Market Potential . You can have these all for a ridiculous Market cap of $30 Million .
There is NOT ONE Biotech out there with such great product pipeline and brutally low market cap like IGXT .I know all Nasdaq and OTC biotechs
Better do your own Due Diligence to realize the Big Potential and this will make you a strong shareholder so the trolls will have no chance to scare you .
Sentiment: Strong Buy
you are 100% correct, also buying up ARRY , and bought DNDN @ 4.20s for the long run